Company Filing History:
12 out of 64 
2 out of 149 
Years Active: 2017-2025
Title: Ram Thaimattam: A Pioneer in Pharmaceutical Innovations
Introduction
Ram Thaimattam, hailing from Hyderabad, Telangana, is a prominent inventor in the field of pharmaceuticals with an impressive portfolio of 13 patents. His work primarily focuses on developing innovative pharmaceutical compositions and processes that significantly contribute to medical science.
Latest Patents
Among his latest inventions are two notable patents. The first is for a novel crystalline form of nilotinib hydrochloride, which includes its preparation process and the pharmaceutical composition that incorporates this innovative form. This work marks a significant advancement in the formulation of treatments using nilotinib. The second patent pertains to the stable amorphous form of sacubitril valsartan trisodium complex, alongside processes for its preparation. This invention also encompasses solid dispersion compounds and highlights an improved process for the preparation of sacubitril sodium, demonstrating his innovative capabilities in complex pharmaceutical formulations.
Career Highlights
Throughout his career, Ram has made significant contributions while working with leading companies in the pharmaceutical industry. He has held positions in Laurus Labs Private Limited and Sun Pharmaceutical Industries Limited, where he has been instrumental in driving research and development initiatives. His expertise and innovative approach have positioned him as a key figure in advancing pharmaceutical research.
Collaborations
In his journey, Ram Thaimattam has collaborated with esteemed colleagues such as Venkata Sunil Kumar Indukuri and Satyanarayana Chava. These collaborations have fostered a dynamic research environment that encourages the exchange of innovative ideas and enhances the quality of their work in pharmaceutical sciences.
Conclusion
In summary, Ram Thaimattam stands out as a leading inventor in the pharmaceutical field, with a robust portfolio of patents that reflect his commitment to innovation and excellence. His contributions not only enhance therapeutic formulations but also pave the way for future discoveries in medicine. His continued efforts in pharmaceutical research will surely leave a lasting impact on the industry and patient care.